Advanced Search

Scientific Opinion on the substantiation of health claims related to Fagopyrum esculentum Moench. and function of the upper respiratory tract (ID 2442) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

EFSA Journal 2009; 7(9):1290 [10 pp.]. doi:10.2903/j.efsa.2009.1290
  EFSA Panel on Dietetic Products, Nutrition and Allergies Panel Members Jean-Louis Bresson, Albert Flynn, Marina Heinonen, Karin Hulshof, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Hildegard Przyrembel, Seppo Salminen, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Henk van den Berg, Hendrik van Loveren and Hans Verhagen Contact nda@efsa.europa.eu
Type: Opinion of the Scientific Committee/Scientific Panel On request from: European Commission Question number: EFSA-Q-2008-3175 Adopted: 02 July 2009 Published: 01 October 2009 Last updated: 26 November 2009. This version replaces the previous one/s. Affiliation: European Food Safety Authority (EFSA), Parma, Italy
Article
  • send
  • print
  • cite
Abstract

No abstract available

Summary

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of Regulation 1924/2006. This opinion addresses the scientific substantiation of health claims in relation to Fagopyrum esculentum Moench. and function of the upper respiratory tract. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders.

The food constituent that is the subject of the health claim is Fagopyrum esculentum Moench.. The Panel considers that Fagopyrum esculentum Moench. has not been sufficiently characterised.

The claimed effect “respiratory health” is not sufficiently defined, but from the wording proposed the Panel assumes that the claimed effect refers to normal function of the upper respiratory tract. The Panel considers that normal function of the upper respiratory tract is beneficial to human health.

One reference was cited to substantiate the claimed effect. This reference was not accessible to the Panel, even after every reasonable effort was made to retrieve it. The Panel concludes that a cause and effect relationship has not been established between the consumption of Fagopyrum esculentum Moench. and normal function of the upper respiratory tract.

Keywords

Fagopyrum esculentum Moench., respiratory tract, health claims

See also